Concepedia

Juan Cantizani

JC

Statistics

Publications

19

Citations

1K

H-Index

15

Active since

2012

Affiliations

GlaxoSmithKline (Spain)(Current)

Fundación Medina

Instituto de Parasitología y Biomedicina "López - Neyra"

Consejo Superior de Investigaciones Científicas

University of Dundee

Juan Cantizani is an author at GlaxoSmithKline (Spain) specializing in drug discovery, pharmacology, and medicinal chemistry.

Publications per year

2012–2023

19

Publications

19

New Compound Sets Identified from High Throughput Phenotypic Screening Against Three Kinetoplastid Parasites: An Open Resource

Imanol Peña, Marlene Manzano, Juan Cantizani et al. · Scientific Reports · 2015 · 258 citations · Full text

, , +17

Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition

Susan Wyllie, Stephen Brand, Michael G. Thomas et al. · Proceedings of the National Academy of Sciences · 2019 · 173 citations · Full text

, , +17

A New Approach to Drug Discovery: High-Throughput Screening of Microbial Natural Extracts against Aspergillus fumigatus Using Resazurin

Maria Cândida Monteiro, Mercedes de la Cruz, Juan Cantizani et al. · SLAS DISCOVERY · 2012 · 143 citations · Full text

, , +15

Automated High-Content Assay for Compounds Selectively Toxic to Trypanosoma cruzi in a Myoblastic Cell Line

Julio Alonso-Padilla, Ignacio Cotillo, Jesús L. Presa et al. · PLoS neglected tropical diseases · 2015 · 70 citations · Full text

, , +16

A Replicative <i>In Vitro</i> Assay for Drug Discovery against Leishmania donovani

Diana Tegazzini, Rosario Díaz-González, Fernando Aguilar et al. · Antimicrobial Agents and Chemotherapy · 2016 · 54 citations · Full text

, , +15

1–5 of 19